|
Contents
|
|
|
|
|
|
|
Astrocytic Tumors
|
|
|
|
Kasumi Araki, Kazuhiko Nozaki,
Tetsuya Ueba, Masaaki Tatsuka and Nobuo Hashimoto
High expression of Aurora-B/Aurora and Ipll-like
midbody-associated protein (AIM-1) in astrocytomas
J Neurooncol. 2004 Mar-Apr;67(1-2):53-64. (Abstract+)
|
|
Teralee Burton, Priti Baijal, Shunzhen Zhang, Elizabeth
Henson, Spencer B. Gibson, David D. Eisenstat
The cell death gene BNIP3 is mutated in astrocytic tumors
Proceedings of the AACR, Volume 45, March 2004. Abstract
Number: 5236
|
|
Basil F. El-Rayes, Camille S. Norton,
Wael Sakr, Zosia Maciorowski, Daryn Smith, Haline Pietraszkiewicz,
Maria Del Mar Alonso and John F. Ensley
Cellular DNA content parameters as
prognostic indicators in human astrocytomas
Journal
of Neuro-Oncology, 71(2):
85-89, January 2005. (Abstract+)
|
|
L. Girard, J. D. Minna, T.
Chen, G. Tomlinson, D. Bowers
Gene expression profiling of progressive and
stable childhood pilocytic astrocytomas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8546
|
|
Koichi
Ichimura, Hiroko Ohgaki, Paul Kleihues, V. Peter Collins
Molecular
pathogenesis of astrocytic tumours
J
Neurooncol, 70(2):137-160,
November 2004.
(Abstract+)
|
|
Stella
M. Ranuncolo, Mirta
Varela, Ana Morandi, José Lastiri, Silvia Christiansen, Elisa Bal de Kier
Joffé, María G. Pallotta, Lydia Puricelli
Prognostic Value of Mdm2, p53 and p16 in
Patients with Astrocytomas
Journal of Neuro-Oncology, 68 (2): 113-121, June 2004.
(Abstract+)
|
|
|
M. Uno, S.M. Oba-Shinjo,
A. Wakamatsu, N. Huang, V. Avancini Ferreira Alves,
S. Rosemberg, P.H. Pires de Aguiar, C. Leite,
F. Miura, R. Marino J., M. Scaff, S.K. Nagahashi-Marie
Association of TP53 mutation, p53 overexpression, and p53 codon 72
polymorphism with susceptibility to apoptosis in adult patients with
diffuse astrocytomas
Int J Biol Markers 2006; 21: 50 - 57 Volume 21 Number
1 (January - March 2006)
.JPG) Abstract
|
|
|
Zhang H, Wu G, Tu H, Huang F.
Discovery of serum biomarkers in astrocytoma by SELDI-TOF MS and
proteinchip technology.
J Neurooncol. 2007
Sep;84(3):315-23. Epub 2007 Apr 24.
Abstract
|
|
|
Brain
Tumors
|
|
|
|
Scott L Carter, Aron C Eklund,
Isaac S Kohane, Lyndsay N Harris & Zoltan
Szallasi
A signature of chromosomal instability inferred from
gene expression profiles predicts clinical outcome in multiple human cancers
Nature Genetics, Advance online publication, Published
online: 20 August 2006; doi:10.1038/ng1861
|
|
Lucinda Aguirre-Cruz, Karima Mokhtari, Khê
Hoang-Xuan, Yannick Marie, Emmanuelle Criniere, Sophie
Taillibert, Manuel Lopes, Jean-Yves Delattre, Marc Sanson
Analysis of the bHLH Transcription Factors Olig1
and Olig2 in Brain Tumors
Journal of Neuro-Oncology, 67 (3): 265-271, May 2004. (Abstract+)
|
|
|
Hainfellner
JA, Heinzl H
Neuropathological biomarker candidates in brain tumors: key issues for
translational efficiency
Clin Neuropathol. 2010 Jan-Feb;29(1):41-54
Abstract | .png)
Reprint
|
|
|
Pozsgai E, Gomori E, Szigeti A, Boronkai A,
Gallyas F Jr, Sumegi B, Bellyei S
Correlation between the progressive cytoplasmic expression of a novel
small heat shock protein (Hsp16.2) and malignancy in brain tumors
BMC Cancer. 2007 Dec 21;7(1):233
[Epub ahead of print]
Abstract
|
Reprint
|
|
Anil
Rajendra, Philip C. Spinella, Henry R. Drott, Troy E. Dominguez,
Leslie Sutton, Mark Helfaer
S-100β
Protein – Serum Levels in Children with Brain Neoplasms and its
Potential as a Tumor Marker
Journal of Neuro-Oncology, 67 (3): 345-349, May 2004. (Abstract+)
|
|
Alan
H. Shih, Eric C. Holland
Developmental
neurobiology and the origin of brain tumors
J
Neurooncol, 70(2):125-135,
November 2004.
(Abstract+)
|
|
|
Edward
R. Smith, MD; David Zurakowski, PhD; Ali Saad, MD; R. Michael Scott, MD;
Marsha A. Moses, PhD
Urinary Biomarkers Predict Brain Tumor Presence and
Response to Therapy
American Association of Neurological Surgeons 76th Annual Meeting: Abstract
629. Presented April 28, 2008
Abstract |
.gif) News
|
|
|
Ependymal
Tumors
|
|
|
|
M. Eva Alonso, M.
Josefa Bello, Pilar Gonzalez-Gomez, Dolores Arjona, Jose M. de Campos, Manuel
Gutierrez and Juan A. Rey
Aberrant CpG island methylation of multiple genes in
ependymal tumors
J Neurooncol. 2004 Mar-Apr;67(1-2):159-65.
(Abstract+)
|
| |
Ebert C, von Haken M,
Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, von Deimling A
Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q
loss occur preferentially in intramedullary spinal ependymomas
Am J
Pathol. 1999 Aug;155(2):627-32. (PDF Full Text)
|
|
Gilhuis HJ, van der Laak J, Wesseling P,
Boerman RH, Beute G, Teepen JL, Grotenhuis JA, Kappelle AC
Inverse correlation between genetic
aberrations and malignancy grade in ependymal tumors: a paradox?
J Neurooncol. 2004 Jan;66(1-2):111-6. (Abstract+)
|
|
Piergiorgio Modena, Joris Weltman, Elena Lualdi, Federica Facchinetti,
Irene Janssen, Lisenka Wissers, Felice Giangaspero, Marco Forni, Gaetano
Finocchiaro, Riccardo Riccardi, Franca Fossati Bellani, Maura Massimino, Eric
Schoenmakers, Gabriella Sozzi
Genome-wide analysis of genomic imbalances in intracranial
ependymomas
Proceedings of the AACR, Volume 45, March 2004. Abstract
Number: 1671
|
|
|
Glioblastoma
|
|
|
|
J.L.
Blanc, M. Wager, J. Guilhot, S. Kusy, B. Bataille, T. Chantereau, F.
Lapierre, C.J. Larsen, L. Karayan-Tapon
Correlation of Clinical Features and Methylation
Status of MGMT Gene Promoter in Glioblastomas
Journal of Neuro-Oncology, 68 (3): 275-283, July 2004. (Abstract+)
|
|
|
Carter AN, Cole CL, Playle AG, Ramsay EJ,
Shervington AA
GPR26: A marker for primary glioblastoma?
Mol Cell Probes. 2007 Oct 26;. [Epub ahead of print]
Abstract
|
|
Charalambous C, Hofman FM, Chen TC
Functional and phenotypic differences between
glioblastoma multiforme-derived and normal human brain endothelial cells
J
Neurosurg. 2005 Apr;102(4):699-705
|
|
|
Etcheverry
A, Aubry M, Tayrac MD, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A,
Riffaud L, Menei P, Quillien V, Mosser J.
DNA methylation in glioblastoma: impact on gene expression and clinical
outcome.
BMC Genomics. 2010 Dec 14;11(1):701. [Epub ahead of print]
Abstract |
Reprint |
.gif)
Related articles
|
|
|
Elstner
A, Stockhammer F, Nguyen-Dobinsky TN, Nguyen QL, Pilgermann I, Gill A, Guhr
A, Zhang T, von Eckardstein K, Picht T, Veelken J, Martuza RL, von Deimling
A, Kurtz A.
Identification of diagnostic serum protein profiles of glioblastoma patients
J Neurooncol. 2010 Jul 9;. [Epub ahead of print]
Abstract
|
|
C. Ford, W. Seiferheld, A. K.
Choucair, J. Hansen, B. Dabbas, C. Schultz, A. Schulsinger, M. Mehta, W. Curran
Evaluation of expression of DNA repair molecules as a
prognostic factor for long-term survivors with glioblastoma multiforme (GBM)
treated on RTOG protocols with irradiation and nitrosoureas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1509
|
|
Inoue
R, Isono M, Abe M,
Abe T, Kobayashi H
A
genotype of the polymorphic DNA repair gene MGMT is associated with de novo
glioblastoma
Neurol Res.
2003 Dec;25(8):875-9
|
|
|
Jung
CS, Foerch C, Schänzer A, Heck A, Plate KH, Seifert V, Steinmetz H, Raabe
A, Sitzer M
Serum GFAP is a diagnostic marker for glioblastoma multiforme
Brain. 2007
Dec;130(Pt 12):3336-41. Epub 2007 Nov 12
Abstract | .png)
Full Text |
Reprint
|
|
H. Kobayashi, N. Ishii, J. Ikeda,
Y. Sawamura, Y. Iwasaki
Methylation profiling of the DNA repair genes in
glioblastoma multiforme and its clinical relevance
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1572
|
|
Yukiko Nakahara, Tetsuya Shiraishi, Hiroaki Okamoto,
Toshihiro Mineta, Tsuyoshi Oishi, Kohsuke Sasaki, Kazuo Tabuchi
Detrended fluctuation analysis of
genome-wide copy number profiles of glioblastomas using array-based
comparative genomic hybridization
Neuro-oncol, 6(4):281-289, Oct 2004. (Abstract+)
|
|
Hiroshi
Nawashiro,
Naoki Otani, Nariyoshi Shinomiya, Shinji Fukui, Hidetoshi Ooigawa, Katsuji
Shima, Hirotaka Matsuo, Yoshikatsu Kanai, Hitoshi Endou
L-type
amino acid transporter 1 as a potential molecular target in human
astrocytic tumors
International Journal of Cancer,
Volume 119, CNO 3, Pages 484 - 492, DOI: 10.1002/ijc.21866, Published Online: 22 Feb 2006
|
|
Pelloski CE, Mahajan A, Maor M, Chang EL, Woo S, Gilbert M, Colman H,
Yang H, Ledoux A, Blair H, Passe S, Jenkins RB, Aldape KD
YKL-40 Expression is Associated with Poorer Response to
Radiation and Shorter Overall Survival in Glioblastoma
Clin
Cancer Res. 2005 May 1;11(9):3326-34
|
|
|
Reddy PS, Umesh S, Thota B, Tandon A, Pandey P,
Hegde AS, Balasubramaniam A, Chandramouli BA, Santosh V, Rao MR, Kondaiah P,
Somasundaram K.
PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma
serum marker with prognostic value
Cancer Biol Ther. 2008 May;7(5):663-8
Abstract
|
|
|
Reddy
SP, Britto R, Vinnakota K, Aparna H, Sreepathi HK, Thota B, Kumari A, Shilpa
BM, Vrinda M, Umesh S, Samuel C, Shetty M, Tandon A, Pandey P, Hegde S,
Hegde AS, Balasubramaniam A, Chandramouli BA, Santosh V, Kondaiah P,
Somasundaram K, Rao MR
Novel Glioblastoma Markers with Diagnostic and Prognostic Value
Identified through Transcriptome Analysis
Clin
Cancer Res. 2008 May 15;14(10):2978-87
Abstract
|
|
F. Rojo, C. Iglesias, J.
Tabernero, J. Jimenez, S. Rodriguez, J. Bellmunt, S. Ramon, J. Baselga
Molecular markers of the mTOR pathway activation
in human tumors: A baseline analysis
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.9524
|
|
Simon, Matthias M.D.; Ludwig, Michael Ph.D.; Fimmers, Rolf Ph.D.; Mahlberg,
Ralph; Muller-Erkwoh, Angelika M.D.; Koster, Gertraud Ph.D.; Schramm, Johannes
M.D.
Variant Of The Chek2 Gene As A Prognostic Marker In Glioblastoma Multiforme.
Clinicopathological Study
Neurosurgery. 2006 Sep 28; [Epub ahead of
print]
Abstract
|
|
|
Sreekanthreddy
P, Srinivasan H, Kumar DM, Nijaguna MB, Sridevi S, Vrinda M, Arivazhagan A,
Balasubramaniam A, Hegde AS, Chandramouli BA, Santosh V, Rao MR, Kondaiah P,
Somasundaram K
Identification
of potential serum biomarkers of glioblastoma: serum osteopontin levels
correlate with poor prognosis
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1409-22
Abstract |
Full Text |
Reprint
|
|
|
Srivastava T, Chattopadhyay P, Mahapatra AK, Sarkar C,
Sinha S
Increased hMSH2 protein expression in glioblastoma
multiforme
J Neurooncol. 2004 Jan;66(1-2):51-7.
(Abstract+)
|
|
Zhang R,
Tremblay TL, McDermid A, Thibault P, Stanimirovic D
Identification
of differentially expressed proteins in human glioblastoma cell lines and tumors
Glia 2003 Apr 15;42(2):194-208
|
|
|
Gliomas
|
|
|
|
Kenichiro
Asano, Christopher D. Duntsch, Qihong Zhou, James D. Weimar, Dwight
Bordelon, Jon H. Robertson, Tayebeh Pourmotabbed
Correlation
of N-cadherin expression in high grade gliomas with tissue invasion
Journal of Neuro-Oncology, 70
(1): 3-15, October 2004. (Abstract+)
|
|
Bradley
SV, Holland EC, Liu GY, Thomas D, Hyun TS, Ross TS.
Huntingtin Interacting Protein 1 Is a Novel Brain Tumor Marker that
Associates with Epidermal Growth Factor Receptor.
Cancer Res. 2007 Apr 15;67(8):3609-15.
PMID: 17440072 [PubMed - in process]
|
|
Conti A, Ageunnouz M, La Torre D,
Cardali S, Angileri FF, Buemi C, Tomasello C, Iacopino DG, D'Avella D,
Vita G, Tomasello F
Expression of the tumor necrosis
factor receptor-associated factors 1 and 2 and regulation of the nuclear
factor-kappaB antiapoptotic activity in human gliomas
J Neurosurg. 2005 Nov;103(5):873-81
|
|
|
de
Groot JF, Gilbert MR.
New molecular targets in malignant gliomas.
Curr Opin
Neurol. 2007 Dec;20(6):712-8.
Abstract
|
|
Tim
Demuth, Michael E. Berens
Molecular
Mechanisms of Glioma Cell Migration and Invasion
J
Neurooncol, 70(2):217-228,
November 2004. (Abstract+)
|
|
Charles
Dichamp, Sophie Taillibert, Lucinda Aguirre-Cruz, Julie Lejeune,
Yannick Marie, Michèle Kujas, Jean-Yves Delattre, Khe Hoang-Xuan and Marc
Sanson
Loss of 14q Chromosome in Oligodendroglial and
Astrocytic Tumors
Journal of Neuro-Oncology, 67 (3): 281-285, May 2004. (Abstract+)
|
|
|
Geiger KD, Hendruschk S, Rieber EP, Morgenroth A, Weigle B, Juratli T, Senner V,
Schackert G, Temme A.
The prostate stem cell antigen represents a novel glioma-associated antigen.
Oncol Rep. 2011 Apr 15;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Griguer
CE, Oliva CR, Gillespie GY
Glucose metabolism heterogeneity in human and mouse malignant glioma cell
lines
J Neurooncol.
2005 Sep;74(2):123-33.
Online 2005 Sep 29
Abstract
|
|
|
Hägerstrand D, Smits A, Eriksson A,
Sigurdardottir S, Olofsson T, Hartman M, Nistér M, Kalimo H, Ostman A.
Gene expression analyses of grade II gliomas and identification of
rPTP{beta}/{zeta} as a candidate oligodendroglioma marker Neuro Oncol. 2007
Nov 14; [Epub ahead of print]
Abstract
|
|
|
Hofer S, Lassman AB.
Molecular
markers in gliomas: impact for the clinician.
Target Oncol. 2010
Sep;5(3):201-10.
Epub 2010 Aug 31.
Abstract |
Reprint |
Related articles
|
|
|
Idbaih A, Omuro A, Ducray F, Hoang-Xuan K
Molecular genetic markers as predictors of response to chemotherapy in
gliomas
Curr Opin
Oncol. 2007 Nov;19(6):606-11
Abstract
|
|
|
Jansen
M, Yip S, Louis DN.
Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive
markers
Lancet Neurol. 2010 Jul;9(7):717-726
Abstract
|
|
Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft
SK, Seyfried NT, Abe T, Chen LB, Carroll RS, Black PM
Expression of cyclooxygenase 2 (COX-2) in human
glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398
Cancer Res 2000 Sep 1;60(17):4926-31(PDF Full Text)
|
|
Balveen
Kaur, Chalet Tan, Daniel J. Brat, Erwin
G. Van Meir
Genetic
and hypoxic regulation of angiogenesis in gliomas
J
Neurooncol, 70(2):229-243,
November 2004. (Abstract+)
|
|
|
Kuhlmann T, Gutenberg A, Schulten HJ, Paulus W,
Rohde V, Bruck W.
Nogo-A Expression in Glial CNS Tumors: A Tool to Differentiate Between
Oligodendrogliomas and Other Gliomas?
Am J Surg Pathol. 2008 Aug 5; [Epub ahead of print]
Abstract
|
|
Leuraud
P, Taillandier L, Aguirre-Cruz L, Medioni J, Criniere E, Marie Y,
Dutrillaux AM, Kujas M, Duprez A, Delattre JY, Poupon MF, Sanson M
Correlation
between genetic alterations and growth of human malignant glioma
xenografted in nude mice
Br J Cancer. 2003 Dec 15;89(12):2327-32
|
|
|
Li
A, Bozdag S, Kotliarov Y, Fine HA.
GliomaPredict: a clinically useful tool for assigning glioma patients to
specific molecular subtypes
BMC Med Inform Decis Mak. 2010 Jul 15;10(1):38. [Epub ahead of print]
Abstract |
Full Text |
Reprint
|
|
Ljubimova JY, Fugita M, Khazenzon NM, Das A, Pikul BB, Newman D, Sekiguchi K,
Sorokin LM, Sasaki T, Black KL
Association between laminin-8 and glial tumor grade,
recurrence, and patient survival
Cancer. 2004 Aug 1;101(3):604-12
|
|
Maher EA,
Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA
Malignant
glioma: genetics and biology of a grave matter
Genes Dev. 2001 Jun 1;15(11):1311-33 (PDF Full Text)
|
|
Q. Richard Lu, John K. Park, Elizabeth Noll,
Jennifer A. Chan, John Alberta, Dongin Yuk, M. Garcia Alzamora, David N. Louis,
Charles D. Stiles, David H. Rowitch, and Peter M. Black
Oligodendrocyte lineage genes (OLIG)
as molecular markers for human glial brain tumors
,
September 11, 2001, Vol. 98, No. 19,
Pages 10851-10856.
(PDF Full Text)
|
|
Timothy E. Van Meter, William C. Broaddus, Harcharan K.
Rooprai, Geoffrey J. Pilkington, Helen L. Fillmore
Induction of membrane-type-1 matrix metalloproteinase
by epidermal growth factor-mediated signaling in gliomas
Neuro-Oncology, Vol. 6, No. 3, July 2004, 188
-- 199. (Abstract+)
|
|
Satoshi
Nakasu, Tadateru Fukami, Kazumi Baba, Masayuki Matsuda
Immunohistochemical
study for O6-methylguanine-DNA methyltransferase in the
non-neoplastic and neoplastic components of gliomas
Journal
of Neuro-Oncology, 70(3):
333-340, December 2004. (Abstract+)
|
|
A.
Ohnishi, M. Tsuda, Y. Sawamura, H. Sawa, K. Nagashima
Testing for glioma uniformity by Olig expression
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No.
467
|
|
Peria
FM, Neder L, Marie SK, Rosemberg S, Oba-Shinjo SM, Colli BO, Gabbai AA,
Malheiros SM, Zago MA, Panepucci RA, Moreira-Filho CA, Okamoto OK, Carlotti CG
Jr.
Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's
correlation with histological diagnosis, microvascular density, cellular
proliferation and overall survival.
J Neurooncol.
2007 Apr 19; [Epub ahead of print]
PMID: 17443289 [PubMed - as supplied by publisher]
|
|
K
Sakai, A Peraud, T Mainprize, J Nakayama, A Tsugu, K Hongo, S Kobayashi, James T.
Rutka
Inducible Expression of p57KIP2
Inhibits Glioma Cell Motility and Invasion
Journal of Neuro-Oncology, 68 (3): 217-223, July 2004. (Abstract+)
|
|
Andrea
Salmaggi, Maurizio Gelati, Bianca Pollo, Simona Frigerio, Marica Eoli,
Antonio Silvani, Giovanni Broggi, Emilio Ciusani, Danilo Croci, Amerigo Boiardi,
Marco De Rossi
CXCL12 in Malignant Glial Tumors: A Possible Role in
Angiogenesis and Cross-Talk between Endothelial and Tumoral Cells
Journal of Neuro-Oncology, 67 (3): 305-317, May 2004. (Abstract+)
|
|
Shono T,
Tofilon PJ, Bruner JM, Owolabi O, Lang FF
Cyclooxygenase-2
expression in human gliomas: prognostic significance and molecular correlations
Cancer Res 2001 Jun 1;61(11):4375-81 (PDF Full Text)
|
|
Joachim
P. Steinbach, Michael Weller
Apoptosis in Gliomas: Molecular Mechanisms and
Therapeutic Implications
J
Neurooncol, 70(2):245-254,
November 2004. (Abstract+)
|
|
Strege RJ, Godt C, Stark AM, Hugo HH, Mehdorn HM
Protein expression of Fas, Fas ligand, Bcl-2 and
TGFbeta2 and correlation with survival in initial and recurrent human gliomas
J Neurooncol. 2004 Mar-Apr;67(1-2):29-39. (Abstract+)
|
|
|
Tanwar MK, Gilbert MR, Holland EC.
Gene expression microarray analysis
reveals YKL-40 to be a potential serum marker for malignant character in human
glioma
Cancer Res 2002 Aug 1;62(15):4364-8
Abstract |
Full Text |
Reprint
|
|
K. D. Weaver, S. Grossman, J.
Herman
Methylated tumor-specific DNA as a plasma
biomarker in patients with glioma
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1527
|
|
Manfred
Westphal, Peter McL. Black
Perspectives of Cellular and Molecular
Neurosurgery
J
Neurooncol, 70(2):255-269,
November 2004. (Abstract+)
|
|
|
R Yamanaka, T Arao,
N Yajima, N Tsuchiya, J Homma, R Tanaka, M Sano,
A Oide, M Sekijima and K Nishio
Identification of expressed genes characterizing long-term survival in
malignant glioma patients
Oncogene advance online publication 1 May 2006;
doi: 10.1038/sj.onc.1209585
Abstract
|
|
Zhang X, Zhao M, Huang AY, Fei Z, Zhang W, Wang
XL
The effect of cyclin D expression on cell proliferation
in human gliomas
J
Clin Neurosci. 2005 Feb;12(2):166-168
|
|
Yi-Hong Zhou, Fang Tan, Kenneth R. Hess
and W. K. Alfred Yung
The Expression of PAX6, PTEN, Vascular Endothelial Growth Factor, and
Epidermal Growth Factor Receptor in Gliomas. Relationship to Tumor Grade and Survival
Clinical Cancer Research Vol. 9, 3369-3375, August 2003. (PDF Full Text)
|
|
|
Gliomas (High-Grade)
|
|
|
|
|
Brommeland
T, Rosengren L, Fridlund S, Hennig R, Isaksen V
Serum levels of glial fibrillary acidic protein correlate to tumour
volume of high-grade gliomas
Acta Neurol Scand.
2007 Dec;116(6):380-4
Abstract
|
|
|
Adília Hormigo, Bin Gu,
Sasan Karimi, Elyn Riedel, Katherine S.
Panageas, Mark A. Edgar, Meena K. Tanwar, Jasti
S. Rao, Martin Fleisher, Lisa M. DeAngelis
and Eric C. Holland
YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for
Patients with High-Grade Gliomas
Clin
Cancer Res. 2006 Oct 1;12(19):5698-704.
|
|
|
Fatima W. Khwaja,
Jonathan S. Duke-Cohan,
Daniel J. Brat and Erwin
G. Van Meir
Attractin Is Elevated in the
Cerebrospinal Fluid of Patients with Malignant Astrocytoma and Mediates
Glioma Cell Migration
Clin
Cancer Res. 2006 Nov 1;12(21):6331-6
|
|
|
Yip S, Iafrate AJ, Louis DN
Molecular diagnostic testing in malignant gliomas: a
practical update on predictive markers
J
Neuropathol Exp Neurol. 2008 Jan;67(1):1-15
Abstract
|
|
|
Wager
M, Menei P, Guilhot J, Levillain P, Michalak S, Bataille B, Blanc JL,
Lapierre F, Rigoard P, Milin S, Duthe F, Bonneau D, Larsen CJ, Karayan-Tapon
L.
Prognostic molecular markers with no impact on decision-making: the
paradox of gliomas based on a prospective study
Br J Cancer.
2008 Jun 3;98(11):1830-8.
Epub 2008 May 27
Abstract
|
|
|
Gliomas
(Low-Grade)
|
|
|
|
|
Bourne TD, Schiff D.
Update
on molecular findings, management and outcome in low-grade gliomas.
Nat
Rev Neurol. 2010 Dec;6(12):695-701. Epub 2010 Nov 2.
Abstract |
Reprint |
Related articles
|
|
J. C. Buckner, K. V. Ballman, B. W.
Scheithauer, R. M. Arusell, H. E. Blair, S. M. Passe, P. D. Brown, K. A.
Jaeckle, E. G. Shaw, R. B. Jenkins
NCCTG 94-72-53: Diagnostic and
prognostic significance of 1p and 19q deletions in patients (pts) with low-grade
oligodendroglioma and astrocytoma
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1502
Journal
of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005: 1502
|
|
Kujas M, Lejeune J, Benouaich-Amiel A, Criniere
E, Laigle-Donadey F, Marie Y, Mokhtari K, Polivka
M, Bernier M, Chretien F, Couvelard A, Capelle
L, Duffau H, Cornu P, Broet P, Thillet J, Carpentier AF, Sanson M, Hoang-Xuan K,
Delattre
JY.
Chromosome 1p loss: A favorable
prognostic factor in low-grade gliomas
Ann Neurol. 2005 Jul 27;58(2):322-326
[Epub ahead of print]
|
|
Ribom
D, Larsson A, Pietras K, Smits A
Growth
factor analysis of low-grade glioma CSF: PDGF and VEGF are not detectable
Neurol
Sci. 2003 Jun;24(2):70-3
|
|
Ribom
D, Westman-Brinkmalm A, Smits A, Davidsson P
Elevated levels of
alpha-2-Heremans-Schmid glycoprotein in CSF of patients with low-grade gliomas
Tumour
Biol. 2003 Mar-Apr;24(2):94-9
|
|
Walker C, du Plessis DG, Fildes D, Haylock B,
Husband D, Jenkinson MD, Joyce KA, Broome J, Kopitski K, Prosser J, Smith T,
Vinjamuri S, Warnke PC
Correlation of molecular genetics
with molecular and morphological imaging in gliomas with an oligodendroglial
component
Clin
Cancer Res. 2004 Nov 1;10(21):7182-91
|
|
|
Hereditary
Tumor Syndr.
|
|
|
|
J. Spaulding, R. Brekken, L. Robinson, K. Koeneman, B. Mickey, J. Cadeddu, C.
Croft, A. Sagalowsky, N. Ahmad, G. E. Tomlinson
Serum markers of angiogenesis in patients with von Hippel-Lindau Disease
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1033
|
|
|
Malignant
Lymphoma
|
|
|
|
L.
E. Abrey, D. A. Filippa, L. M. DeAngelis
Clinical
correlation of histologic and genetic features in primary CNS lymphoma (PCNSL)
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 417
|
|
|
Medulloblastoma
|
|
|
|
Boon K, Eberhart CG, Riggins GJ
Genomic amplification of orthodenticle homologue 2 in
medulloblastomas
Cancer
Res. 2005 Feb 1;65(3):703-7
|
|
|
Brandes AA, Franceschi E.
Neuro-oncology:
Genetic variation in pediatric and adult brain tumors.
Nat
Rev Neurol. 2010 Dec;6(12):653-4.
Abstract |
Related articles
|
|
Di C, Liao S, Adamson DC, Parrett TJ, Broderick DK, Shi Q, Lengauer C,
Cummins JM, Velculescu VE, Fults DW, McLendon RE, Bigner DD, Yan H
Identification of OTX2 as a Medulloblastoma Oncogene
Whose Product can be Targeted by All-Trans Retinoic Acid
Cancer
Res. 2005 Feb 1;65(3):919-24. (Abstract+)
|
|
Fernandez-Teijeiro A, Betensky RA, Sturla LM, Kim JY, Tamayo P, Pomeroy SL
Combining
Gene Expression Profiles and Clinical Parameters for Risk Stratification in
Medulloblastomas
Journal
of Clinical Oncology, Vol 22, No 6 (March 15), 2004: pp. 994-998
(PDF Full Text)
|
|
Paul Graham Fisher, Peter C. Burger, Charles G.
Eberhart
Biologic Risk
Stratification of Medulloblastoma: The Real Time Is Now
Journal of
Clinical Oncology, Vol 22, No 6
(March 15), 2004: pp. 971-974. (PDF Full Text)
|
|
Amar Gajjar, Roberto Hernan, Mehmet Kocak,
Christine Fuller, Youngsoo Lee, Peter J.
McKinnon, Dana Wallace, Ching Lau, Murali
Chintagumpala, David M. Ashley, Stewart J.
Kellie, Larry Kun, Richard J. Gilbertson
Clinical,
Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease
Risk Stratification System for Medulloblastoma
Journal of Clinical
Oncology, Vol 22, No 6 (March 15), 2004: pp. 984-993. (Full Text)
|
|
A.
J. Gajjar, R. Hernan, C. Fuller, Y. Lee, M. Kocak, C. Lau, M. Chintagumpala,
D. Ashley, S. Kellie, R. Gilbertson
Molecular markers predictive of disease
outcome in medulloblastoma
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
|
|
|
Holland H, Koschny R, Krupp W, Meixensberger J,
Bauer M, Schober R, Kirsten H, Ganten TM, Ahnert P.
Cytogenetic and molecular biological characterization of an adult
medulloblastoma.
Cancer Genet Cytogenet.
2007 Oct 15;178(2):104-13.
Abstract
|
|
Jung HL, Wang KC, Kim SK, Sung KW, Koo HH,
Shin HY, Ahn HS, Shin HJ, Cho BK
Loss of heterozygosity analysis of
chromosome 17p13.1-13.3 and its correlation with clinical outcome
in medulloblastomas
J Neurooncol. 2004 Mar-Apr;67(1-2):41-6. (Abstract+)
|
|
Brian R. Rood, Huizhen Zhang, Philip H. Cogen
Intercellular heterogeneity of expression of the MGMT
DNA repair gene in pediatric medulloblastoma
Neuro-Oncology, Vol. 6, No. 3, July
2004,
200 -- 207. (Abstract+)
|
|
Tong CY, Hui AB, Yin XL, Pang JC, Zhu XL, Poon WS,
Ng HK
Detection of oncogene amplifications in
medulloblastomas by comparative genomic hybridization and array-based
comparative genomic hybridization
J Neurosurg. 2004 Feb;100(2 Suppl):187-93
|
|
|
Meningioma
|
|
|
|
Bernhard
Braun, Manfred Lange, Reinhard Oeckler,
Margareta M. Mueller
Expression of G-CSF and GM-CSF in Human Meningiomas Correlates with
Increased Tumor Proliferation and Vascularization
Journal of Neuro-Oncology, 68 (2): 131-140, June 2004. (Abstract+)
|
|
Angel Maíllo, Alberto Orfao, José
María Sayagués, Pedro Díaz, Juan Antonio Gómez-Moreta,
Marcelino Caballero, David Santamarta, Angel
Santos-Briz, Francisco Morales, María Dolores
Tabernero
New Classification Scheme for the Prognostic Stratification of Meningioma on
the Basis of Chromosome 14 Abnormalities, Patient Age, and Tumor Histopathology
Journal of Clinical Oncology, Vol 21, No 17
(September 1), 2003: 3285-3295. (PDF Full
Text)
|
|
Okada M, Miyake K, Matsumoto Y, Kawai N, Kunishio K, Nagao
S
Matrix metalloproteinase-2 and matrix
metalloproteinase-9 expressions correlate with the recurrence of intracranial
meningiomas
J Neurooncol. 2004 Jan;66(1-2):29-37. (Abstract+)
|
|
Shinji
Otsuka, Takashi Tamiya, Yasuhiro Ono, Hiroyuki Michiue, Kazuhiko Kurozumi,
Shigeru Daido, Hirokazu Kambara, Isao Date, Takashi Ohmoto
The
relationship between peritumoral brain edema and the expression of vascular
endothelial growth factor and its receptors in intracranial meningiomas
Journal
of Neuro-Oncology, 70(3):
349-357, December 2004. (Abstract+)
|
|
Arie
Perry, David H. Gutmann, Guido Reifenberger
Molecular
pathogenesis of meningiomas
J
Neurooncol, 70(2):183-202,
November 2004.
(Abstract+)
|
|
Torsten
Pietsch, Michael D. Taylor, James T. Rutka
Molecular
pathogenesis of childhood brain tumors
J
Neurooncol, 70(2):203-215,
November 2004. (Abstract+)
|
|
Wolfgang K. Pfisterer, Nicole C. Hank, Mark
C. Preul, William P. Hendricks, Jeanette Pueschel, Stephen W.
Coons, Adrienne C. Scheck
Diagnostic and prognostic
significance of genetic regional heterogeneity in meningiomas
Neuro-oncol, 6(4):290-299, Oct 2004. (Abstract+)
|
|
|
Metastatic
Tumors |
|
|
|
|
Saad AG, Yeap BY, Thunnissen FB, Pinkus GS,
Pinkus JL, Loda M, Sugarbaker DJ, Johnson BE, Chirieac LR.
Immunohistochemical markers associated with brain metastases in patients
with nonsmall cell lung carcinoma
Cancer. 2008 Aug 20. [Epub
ahead of print]
Abstract
|
|
|
Neuroblastoma |
|
|
|
J. Mora, M. Alaminos, N.-K. Cheung,
J. Rios, W. Gerald
Gene expression profiling of neuroblastoma: Analysis of
nonmetastatic versus metastatic tumors
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8538
|
|
Weber A, Huesken C, Bergmann E, Kiess W, Christiansen NM, Christiansen
H
Coexpression of insulin receptor-related receptor and
insulin-like growth factor 1 receptor correlates with enhanced apoptosis and
dedifferentiation in human neuroblastomas
Clin Cancer Res. 2003 Nov 15;9(15):5683-92. (PDF Full Text)
|
|
|
Non-Nervous
System Tum. |
|
|
|
|
S
Fan, Q Meng, K Auborn, T Carter and E M Rosen
BRCA1
and BRCA2 as molecular targets for phytochemicals indole-3-carbinol
and genistein in breast and prostate cancer cells
British Journal of Cancer
(2006) 94, 407-426.
Published online 24 January 2006
Abstract
| BrainLife |
Full
Text |
Reprint
|
News
|
|
|
Oligodendroglial
Tumors
|
|
|
|
L. S. Ashby, J. K. Pueschel, A. C.
Scheck, S. W. Coons, W. R. Shapiro
Prognostic factors for
patients with newly diagnosed low-grade oligodendroglial tumors: molecular
genetics, histopathology, and neuroimag
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1501
Journal
of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005: 1501
|
|
Sandra H. Bigner, Mark
R. Matthews, B. K. A. Rasheed, Rodney N. Wiltshire,
Henry S. Friedman, Allan H. Friedman, Timothy
T. Stenzel, Donald M. Dawes, Roger E. McLendon
and Darell D. Bigner
Molecular Genetic Aspects of
Oligodendrogliomas Including Analysis by Comparative Genomic Hybridization
American Journal of Pathology. August 1999;155:375-386. (PDF Full Text)
|
|
JG Cairncross, K Ueki, MC Zlatescu, DK
Lisle, DM Finkelstein, RR Hammond, JS Silver, PC Stark, DR Macdonald, Y Ino,
DA Ramsay and DN Louis
Specific genetic predictors
of chemotherapeutic response and survival in patients with anaplastic
oligodendrogliomas
Journal Of The National Cancer Institute, Vol 90, 1473-1479; 7 October 1998.
(PDF Full Text)
|
|
E. Franceschi, G. Cavallo, A. Paioli, L. Scopece, R. Degli
Esposti, E. Leonardi, F. Spagnolli, A. M. Cremonini, A. Pession,
L. Crino
Evaluation of 1p and 19q chromosomal alterations in
oligodendroglial neoplasms using microdissection and
microsatellite analysis technique and correlations with response
to chemotherapy
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1568
|
|
M.T. Giordana, C.
Ghimenti, E. Leonardo, I. Balteri, M. Iudicello, D. Duò
Molecular Genetic
Study of a Metastatic Oligodendroglioma
Journal of Neuro-Oncology, 66 (3): 265-271, February 2004 (Abstract+)
|
|
Hamlat A, Saikali S, Chaperon J,
Le Calve M, Gedouin D, Ben-Hassel M, Guegan Y
Oligodendroglioma: clinical study and
survival analysis correlated with chromosomal anomalies
Neurosurg Focus.
2005 Nov 15;19(5):E15
|
|
Hoang-Xuan
K, He J, Huguet S, Mokhtari K, Marie Y, Kujas M, Leuraud P,
Capelle L, Delattre JY, Poirier J, Broet P, Sanson M
Molecular
heterogeneity of oligodendrogliomas suggests alternative
pathways in tumor progression
Neurology.
2001 Oct 9;57(7):1278-81
|
|
Judith
W.M. Jeuken, Andreas Von Deimling, Pieter Wesseling
Molecular
pathogenesis of oligodendroglial tumors
J
Neurooncol, 70(2):161-181,
November 2004.
(Abstract+)
|
|
Laigle-Donadey
F, Martin-Duverneuil N, Lejeune J, Criniere E, Capelle L, Duffau H, Cornu P,
Broet P, Kujas M, Mokhtari K, Carpentier A, Sanson M, Hoang-Xuan K, Thillet J,
Delattre JY
Correlations between
molecular profile and radiologic pattern in oligodendroglial tumors
Neurology.
2004 Dec 28;63(12):2360-2
|
|
Marie
Y, Sanson M, Mokhtari K, Leuraud P, Kujas M, Delattre JY, Poirier J,
Zalc B, Hoang-Xuan K
OLIG2 as a specific marker of
oligodendroglial tumour cells
Lancet.
2001 Jul 28;358(9278):298-300
|
|
Mokhtari
K, Paris S, Aguirre-Cruz L, Privat N, Criniere E, Marie Y, Hauw JJ,
Kujas M, Rowitch D, Hoang-Xuan K, Delattre JY, Sanson M
Olig2
expression, GFAP, p53 and 1p loss analysis contribute to glioma
subclassification
Neuropathol
Appl Neurobiol. 2005 Feb;31(1):62-9
|
|
Walker C, du Plessis DG, Joyce KA,
Fildes D, Gee A, Haylock B, Husband D, Smith T, Broome J, Warnke PC
Molecular pathology and clinical
characteristics of oligodendroglial neoplasms
Ann Neurol. 2005 Jun;57(6):855-65
|
|
|
Weller
M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex
D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A; German
Glioma Network
Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic
biomarker?
Clin
Cancer Res. 2007 Dec 1;13(23):6933-7
Abstract
|
|
|
Primer
|
|
|
|
|
Ivanchuk SM, Rutka JT
The cell cycle: accelerators, brakes, and
checkpoints
Neurosurgery. 2004 Mar;54(3):692-9; discussion 699-700. (Abstract+)
|
|
|
Schwannoma |
|
|
|
A. M. Cappellano, M.
T. Grande, S. N. Oliveira, L. J. G. Zambaldi, M. Araujo, F. A.
Freitas, I. A. Cardinalli, S. R. Brandalise, S. S. Aguiar
A novel translocation
(x;4)(p22.1;q32) in a child with malignant Schwannoma
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8572
|
|
|
SPNET
|
|
|
|
VE
Gould, DS Jansson, WM Molenaar, LB Rorke, JQ Trojanowski, VM Lee, RJ Packer
and WW Franke
Primitive
neuroectodermal tumors of the central nervous system. Patterns of expression of
neuroendocrine markers, and all classes of intermediate filament proteins
Lab Invest. 1990 Apr;62(4):498-509
|
|
